We studied 44 patients undergoing minor gynaecological surgery, anaesthetized in random order with sevoflurane-nitrous oxide or propofol-alfentanil-nitrous oxide. Operating conditions, recovery and postoperative nausea and vomiting (PONV) were assessed. For postoperative analgesia, all patients were given ketoprofen 100 mg rectally at the end of anaesthesia. Patients and gynaecologists were equally satisfied with both anaesthetic techniques. Patients given propofol woke up (3.5 vs 6.5 min), became orientated (5.0 vs 7.5 min) and were able to walk (57 vs 69 min) significantly (PϽ0.05) earlier than those given sevoflurane, but there were no differences in times to achieve home readiness (166 vs 149 min) or in psychomotor recovery between the two groups. Intrauterine bleeding and PONV were more common with sevoflurane (incidence of PONV 64%) than with propofol anaesthesia (incidence of PONV 5%). We conclude that propofol-alfentanil is preferable to sevoflurane in ultra-short anaesthesia for minor gynaecological surgery.
Propofol, supplemented with nitrous oxide and opioids, is used as anaesthesia for termination of pregnancy. 1 A single i.v. bolus dose of propofol may have too short a duration of action for the whole operation while continuous infusion of propofol may be impractical for this ultra-short procedure. 2 Unpredictable movement of the patient may entail a risk of surgical complications, such as perforation of the uterus. An anaesthetic mixture of sevoflurane-nitrous oxide provides fast induction and adequate maintenance of anaesthesia, with rapid emergence. [3] [4] [5] We tested the hypothesis that induction of anaesthesia with sevoflurane-nitrous oxide using the single-breath technique and maintenance by spontaneous breathing, would offer fast recovery and better operating conditions compared with propofol-nitrous oxide-alfentanil anaesthesia. Special attention was paid to the incidence of postoperative nausea and vomiting, and intraoperative bleeding.
Patients and methods
After obtaining approval from the Ethics Committee of the hospital and written informed consent, we studied 44 healthy women undergoing elective dilatation and evacuation for termination of pregnancy or for miscarriage within the first © British Journal of Anaesthesia 12 weeks of pregnancy. The sample size was based on our previous studies. 1 6 Inclusion criteria were age more than 18 yr, normal weight (body mass index Ͻ27 kg m -2 ), no contraindications to the anaesthetics used in the study or known allergy to ketoprofen. For gynaecological reasons, prostaglandin E1 vagitorium (Cervagem) was administrated to all patients. All patients were unpremedicated. A baseline value for a psychomotor test (digit symbol substitution test (DSST, time 2 min)) was assessed 2 h before operation.
Patients were allocated randomly to receive sevofluranenitrous oxide or propofol-alfentanil-nitrous oxide anaesthesia (sequential coded envelopes). In all patients, a cubital vein was cannulated on arrival in the operating theatre. Routine anaesthesia monitoring and record keeping were performed.
Anaesthesia in patients receiving sevoflurane was induced using the single-breath inhalation technique. 4 All patients breathed oxygen via a clear face mask for 2 min before induction. After priming the semi closed breathing system (fresh gas flow 8 litre min -1 ) with 8% sevoflurane and 50% nitrous oxide in oxygen, patients were asked to exhale fully, then to take a deep breath with a face mask placed over the nose and mouth, and then to hold their breath for as long as possible. Thereafter patients were asked to breathe normally. After loss of the eyelash and trapezius squeeze reflexes, the concentration of sevoflurane was decreased to 3% end-tidal, and the vaporizer was switched off 1-2 min before the anticipated end of surgery. Nitrous oxide was discontinued at the end of operation.
For patients receiving propofol, i.v. bolus doses of alfentanil 0.5 mg and lidocaine 10 mg were given 2 min before induction of anaesthesia. Anaesthesia was induced with propofol 2.0-2.5 mg kg -1 . Additional boluses of propofol, 25% of the induction dose, were given if the patient moved. Patients breathed spontaneously a mixture of 50% nitrous oxide in oxygen. Nitrous oxide was discontinued at the end of surgery (considered as the end of anaesthesia). Ketoprofen 100 mg rectally and methylergometrine 0.2 mg i.v. were given to all patients at the end of operation.
To monitor consciousness, patients were asked to squeeze the observer's hand repeatedly. During induction of anaesthesia, when the patient stopped responding to the commands, eyelash and trapezius squeezing reflexes were tested. Disappearance of these reflexes was interpreted as unconsciousness. After operation, the patient was called by name. The times elapsed from discontinuing nitrous oxide to spontaneous eye opening, to following orders and to orientation in time and place were recorded. In the post-anaesthesia care unit (PACU) the patient was encouraged to drink and ambulate at 20-min intervals at least. To evaluate psychomotor recovery, patients were asked to complete the DSST at 15, 30, 60, 90 and 120 min after discontinuing nitrous oxide, or until they regained baseline performance. Home readiness was evaluated in the phase II recovery room. This included ability to pass urine.
The gynaecologist was blinded to the anaesthesia method and was not present during induction of anaesthesia; there was an opaque curtain between the anaesthesia and surgical teams to prevent the gynaecologist from seeing the anaesthesia devices. The gynaecologist's satisfaction with the operating conditions was recorded using a 10-cm visual analogue scale (VAS) with 0ϭworst possible working conditions and 10ϭfully satisfied. The gynaecologist also evaluated intraoperative blood loss using a three-point scale: less than average, average or more than average. Fentanyl 0.05 mg i.v. and an additional dose of ketoprofen 100 mg i.v. were given in a standard manner for pain in the PACU. In the phase II recovery room, pain was treated with ketoprofen and paracetamol. The severity of pain was evaluated in the PACU and in the phase II recovery room using a four-point scale: no pain, mild, moderate or severe. Postoperative nausea and vomiting (PONV) were evaluated similarly, using a four-point scale: no PONV, nausea Ͻ15 min, prolonged nausea Ͼ15 min or vomiting. Each patient was rated only once, according to her worst symptom. Prolonged nausea or vomiting was treated with droperidol 0.01 mg kg -1 i.v. All patients were interviewed before discharge from hospital. We asked them for any memories associated with induction of anaesthesia, the intraoperative 
Results
Patient characteristics were similar in both groups (Table 1) ; 59% of patients in the sevoflurane group and 68% in the propofol group had undergone a previous anaesthetic.
PONV in the PACU was significantly (PϽ0.01) more common after sevoflurane (64%) than after propofol (5%) anaesthesia (Table 2) . Only patients anaesthetized with sevoflurane required antiemetics (36% vs 0%; PϽ0.01). In the phase II recovery room, patients had only brief (Ͻ15 min) periods of PONV. Five patients in the sevoflurane group and two patients in the propofol group had nausea, but no antiemetics were needed.
There were no differences between groups in the incidence or severity of pain or pain medication in hospital (Table 2 ). In the phase II recovery room, 50% of patients in both groups had no pain. Three patients who received sevoflurane and two who received propofol required one dose of pain medication. 
Sevoflurane Propofol
Open eyes spontaneously (min) 6. The time needed for induction of anaesthesia was slightly longer in the sevoflurane group (median end-tidal sevoflurane concentration at induction 3.2 (interquartile range (IQR) 0.6) %), while operation times were similar in both groups (Table 1) . Emergence from anaesthesia was faster after propofol than after sevoflurane (end-tidal sevoflurane concentration at the end of anaesthesia 0.9 (0.6) %) ( Table 3) . Patients in the propofol group were able to walk significantly (PϽ0.05) earlier than those given sevoflurane (52 vs 65 min, respectively). There was no difference in the time to achieve home readiness between groups (Table 3) . Psychomotor recovery did not depend on the anaesthetic used (Fig. 1) . One patient in each group did not regain baseline psychomotor performance during the testing period.
Additional bolus doses of propofol were needed in 95% of patients anaesthetized with propofol (median total amount 190 (IQR 43) mg). However, there were no differences in the gynaecologist's satisfaction with operating conditions between the anaesthesia methods (median VAS 8.5 in the sevoflurane group and 7.2 in the propofol group). The gynaecologists estimated blood loss to be greater in patients receiving sevoflurane. In the sevoflurane group, the percentage of patients whose intraoperative bleeding was estimated as less than average was 4.5%, average 68.2% and abundant 27.3%, whereas the respective percentages in the propofol group were 22.7%, 72.7% and 4.5% (PϽ0.05 between groups).
Pre-anaesthetic haemodynamic variables were similar in both groups. After induction of anaesthesia, arterial pressure decreased significantly more (PϽ0.05) after propofol than after sevoflurane induction, but thereafter there were no differences between groups. Heart rate increased slightly during induction with sevoflurane, while it decreased in patients who received propofol (PϽ0.05).
Satisfaction of patients with their anaesthetic was high: 19 of 22 (86%) patients in the sevoflurane group and all patients in the propofol group were willing to accept a similar anaesthesia again. The three patients in the sevoflurane group who disliked their anaesthesia complained about the unpleasant smell of sevoflurane. Subjectively, both anaesthesia methods offered fast induction of anaesthesia without recall of intraoperative events.
Discussion
The main result of our study was that sevoflurane with nitrous oxide did not provide better anaesthetic or operating conditions than propofol-alfentanil-nitrous oxide anaesthesia. The most significant difference between groups was observed in the PACU. Patients who received sevoflurane experienced more PONV than those who received propofolalfentanil anaesthesia and they also required antiemetic medication. Operating conditions were worse because of greater intrauterine bleeding during sevoflurane anaesthesia than during propofol anaesthesia.
A similar tendency to increased PONV after a short anaesthetic was found by Thwaites, Edmends and Smith. 5 They reported that PONV was less common when propofol was used to induce sevoflurane anaesthesia than when sevoflurane was used without propofol in patients undergoing short cystoscopy. However, our patients were women of fertile age. Hormonal status has been reported to affect the risk of PONV in gynaecological operations. Few studies have been published on inhaled anaesthetics and recovery after minor gynaecological procedures. When halothane anaesthesia was compared with i.v. fentanyl anaesthesia, PONV was more common in patients receiving i.v. fentanyl. 7 Several other anaesthetics have been compared in patients undergoing termination of pregnancy: eltanolol vs thiopental or propofol, thiopental vs propofol supplemented with alfentanil or fentanyl and propofol boluses vs continuous infusion. 1 2 6 8 In studies in which nausea or antiemetic medication was studied, its incidence was low. However, even if PONV in our study was an unpleasant side effect complicating recovery after anaesthesia, it was not a great inconvenience to patients receiving sevoflurane, because 86% were willing to have the same anaesthetic again.
Our study population consisted of homogeneous patient groups undergoing an elective, short (Ͻ15 min) outpatient operation in which the need for analgesia afterwards was expected to be minimal. Postoperative analgesia may be associated with a high incidence of PONV. 9 Not only PONV but the abundant use of opioids and antiemetics, such as droperidol, delay recovery after surgery. In contrast with previous studies of sevoflurane and propofol in outpatient populations, 10 11 we anaesthetized patients in the sevoflurane group with sevoflurane and 50% nitrous oxide in oxygen without opioids or any other premedication. No opioids were given with sevoflurane induction to easily maintain spontaneous ventilation. 3 In unpremedicated adults, more collaboration may be needed between the patient and anaesthetist to achieve pleasant induction with inhaled anaesthetic compared with i.v. induction. Despite the longer induction time in the sevoflurane group, as also reported in previous studies, 5 12 duration of anaesthesia was similar in both groups.
Previous studies have shown that inhaled anaesthetics relax uterine muscle. 13 We assumed that the effect of sevoflurane would also provide better operating conditions for the gynaecologist, for example by relaxing the uterus and thus helping the gynaecologist to perform the procedure. However, it seems that because sevoflurane relaxes smooth muscle, the use of sevoflurane in this patient population was associated with more intraoperative uterine bleeding compared with propofol. Hall, Ng and Smith 14 compared two groups of patients in whom anaesthesia for termination of pregnancy was induced with propofol; in one group, anaesthesia was maintained with isoflurane and in the other with infusion of propofol. In agreement with our results, they found that blood loss was greater in patients receiving an inhaled anaesthetic for maintenance of anaesthesia compared with propofol. Although of no other clinical relevance, this bleeding may mislead the gynaecologist to continue the curettage unnecessarily.
Early recovery (opening eyes spontaneously, following orders, and orientation in time and place) was 2-3 min longer in the sevoflurane group. It is difficult to compare the depth of anaesthesia between inhaled and i.v. anaesthetics. Throughout the operation, we maintained anaesthesia at a clinically adequate level with both sevoflurane and propofol.
In our study, mean arterial pressure was more stable in the sevoflurane than in the propofol group, as also reported by Thwaites, Edmends and Smith. 5 Heart rate decreased in the propofol group after induction, as is expected as a result of its cardiovascular depressive effects. 5 However, a heart rate of 47 beat min -1 was the lowest value during surgery, and no medication was needed to treat bradycardia. As in a previous study, 4 comparing induction techniques between sevoflurane using the single-breath technique and propofol, we found a similar trend of increased heart rate in the sevoflurane group but not in the propofol group. In our study, alfentanil given before induction possibly had an additional slowing effect on heart rate.
In summary, induction and maintenance of anaesthesia with sevoflurane were associated with more PONV and intrauterine bleeding than with propofol-alfentanil. Patients 579 who received propofol woke up and were able to walk earlier than patients given sevoflurane, but there were no other differences in variables measuring home readiness. Propofol-alfentanil anaesthesia is preferable to sevoflurane anaesthesia in this patient population.
